Lifetime risk of herpes zoster in the population of Beijing, China

Objectives: We aimed to estimate the current and future lifetime risks (LTR) of herpes zoster (HZ) and postherpetic neuralgia (PHN), as well as their respective number of annual incident cases in Beijing, China, if individuals were not vaccinated against HZ. Study design: Mathematical model built in...

Full description

Bibliographic Details
Main Authors: Christa Lee, Nikolaos Giannelos, Desmond Curran, Hengjin Dong, Haiwen Tang, Ning Jiang, Chiyu Ye, Yanfei Yuan, Cheryl Ng
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Public Health in Practice
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666535223000022
_version_ 1797806406642958336
author Christa Lee
Nikolaos Giannelos
Desmond Curran
Hengjin Dong
Haiwen Tang
Ning Jiang
Chiyu Ye
Yanfei Yuan
Cheryl Ng
author_facet Christa Lee
Nikolaos Giannelos
Desmond Curran
Hengjin Dong
Haiwen Tang
Ning Jiang
Chiyu Ye
Yanfei Yuan
Cheryl Ng
author_sort Christa Lee
collection DOAJ
description Objectives: We aimed to estimate the current and future lifetime risks (LTR) of herpes zoster (HZ) and postherpetic neuralgia (PHN), as well as their respective number of annual incident cases in Beijing, China, if individuals were not vaccinated against HZ. Study design: Mathematical model built in Microsoft Excel, de novo. Methods: A hypothetical cohort of 1,000 people was simulated from age 0–100 or until death to generate LTRs of HZ/PHN in Beijing, China. LTR was defined as the risk of developing HZ/PHN at least once in the person’s lifetime. The current number of annual incident HZ/PHN cases were also calculated by multiplying up-to-date population data and the annual age-specific incidence of HZ/PHN. For both LTR and annual incident cases, current estimates were projected into the year 2035 to investigate the impact of an aging population. Scenario and deterministic sensitivity analyses (DSA) were conducted to validate the model outcomes. Results: In Beijing, the current and future LTRs of HZ (PHN) were 32.4% (2.8%) and 34.8% (3.3%), respectively. The current and future annual incident cases of HZ (PHN) of individuals aged ≥50 years were 68,394 (7,801) cases among 7.04 million individuals and 88,676 (9,649) cases among 9.08 million individuals, respectively. The scenario analyses demonstrated that modelled results were likely to underestimate the LTR of HZ. Results were robust under the DSA. Conclusions: Given an aging population, HZ poses a significant, growing burden on individuals, the society, and healthcare system of China, highlighting the need for preventative measures such as vaccination.
first_indexed 2024-03-13T06:06:49Z
format Article
id doaj.art-eb179e0c8a7d4190ad8d66d331ae5ded
institution Directory Open Access Journal
issn 2666-5352
language English
last_indexed 2024-03-13T06:06:49Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Public Health in Practice
spelling doaj.art-eb179e0c8a7d4190ad8d66d331ae5ded2023-06-12T04:09:33ZengElsevierPublic Health in Practice2666-53522023-06-015100356Lifetime risk of herpes zoster in the population of Beijing, ChinaChrista Lee0Nikolaos Giannelos1Desmond Curran2Hengjin Dong3Haiwen Tang4Ning Jiang5Chiyu Ye6Yanfei Yuan7Cheryl Ng8GSK, Singapore, SingaporeGSK, Wavre, BelgiumGSK, Wavre, BelgiumCenter for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, ChinaGSK, Beijing, ChinaGSK, Beijing, ChinaGSK, Beijing, ChinaGSK, Beijing, ChinaGSK, Singapore, Singapore; Corresponding author. GSK, Asia House, 23 Rochester Park, 139234, Singapore.Objectives: We aimed to estimate the current and future lifetime risks (LTR) of herpes zoster (HZ) and postherpetic neuralgia (PHN), as well as their respective number of annual incident cases in Beijing, China, if individuals were not vaccinated against HZ. Study design: Mathematical model built in Microsoft Excel, de novo. Methods: A hypothetical cohort of 1,000 people was simulated from age 0–100 or until death to generate LTRs of HZ/PHN in Beijing, China. LTR was defined as the risk of developing HZ/PHN at least once in the person’s lifetime. The current number of annual incident HZ/PHN cases were also calculated by multiplying up-to-date population data and the annual age-specific incidence of HZ/PHN. For both LTR and annual incident cases, current estimates were projected into the year 2035 to investigate the impact of an aging population. Scenario and deterministic sensitivity analyses (DSA) were conducted to validate the model outcomes. Results: In Beijing, the current and future LTRs of HZ (PHN) were 32.4% (2.8%) and 34.8% (3.3%), respectively. The current and future annual incident cases of HZ (PHN) of individuals aged ≥50 years were 68,394 (7,801) cases among 7.04 million individuals and 88,676 (9,649) cases among 9.08 million individuals, respectively. The scenario analyses demonstrated that modelled results were likely to underestimate the LTR of HZ. Results were robust under the DSA. Conclusions: Given an aging population, HZ poses a significant, growing burden on individuals, the society, and healthcare system of China, highlighting the need for preventative measures such as vaccination.http://www.sciencedirect.com/science/article/pii/S2666535223000022Aging populationChinaHerpes zosterLifetime riskPostherpetic neuralgiaVaccination
spellingShingle Christa Lee
Nikolaos Giannelos
Desmond Curran
Hengjin Dong
Haiwen Tang
Ning Jiang
Chiyu Ye
Yanfei Yuan
Cheryl Ng
Lifetime risk of herpes zoster in the population of Beijing, China
Public Health in Practice
Aging population
China
Herpes zoster
Lifetime risk
Postherpetic neuralgia
Vaccination
title Lifetime risk of herpes zoster in the population of Beijing, China
title_full Lifetime risk of herpes zoster in the population of Beijing, China
title_fullStr Lifetime risk of herpes zoster in the population of Beijing, China
title_full_unstemmed Lifetime risk of herpes zoster in the population of Beijing, China
title_short Lifetime risk of herpes zoster in the population of Beijing, China
title_sort lifetime risk of herpes zoster in the population of beijing china
topic Aging population
China
Herpes zoster
Lifetime risk
Postherpetic neuralgia
Vaccination
url http://www.sciencedirect.com/science/article/pii/S2666535223000022
work_keys_str_mv AT christalee lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT nikolaosgiannelos lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT desmondcurran lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT hengjindong lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT haiwentang lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT ningjiang lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT chiyuye lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT yanfeiyuan lifetimeriskofherpeszosterinthepopulationofbeijingchina
AT cherylng lifetimeriskofherpeszosterinthepopulationofbeijingchina